BMS 433796, with the CAS number 935525-13-6, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound exhibits selective inhibition of specific kinases, which are enzymes that play crucial roles in various cellular processes, including signal transduction and cell division. BMS 433796 is characterized by its ability to modulate biological activity at the molecular level, making it a candidate for therapeutic applications. Its chemical structure includes functional groups that contribute to its binding affinity and specificity for target proteins. In preclinical studies, it has shown promise in inhibiting tumor growth and enhancing the efficacy of existing cancer treatments. However, as with many investigational drugs, further studies are necessary to fully understand its pharmacokinetics, safety profile, and potential side effects in humans.

BMS 433796;

935525-13-6: BMS 433796, with the CAS number 935525-13-6, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound exhibits selective inhibition of specific kinases, which are enzymes that play crucial roles in various cellular processes, including signal transduction and cell division. BMS 433796 is characterized by its ability to modulate biological activity at the molecular level, making it a candidate for therapeutic applications. Its chemical structure includes functional groups that contribute to its binding affinity and specificity for target proteins. In preclinical studies, it has shown promise in inhibiting tumor growth and enhancing the efficacy of existing cancer treatments. However, as with many investigational drugs, further studies are necessary to fully understand its pharmacokinetics, safety profile, and potential side effects in humans.

BMS 433796

<p>BMS 433796 is a γ-secretase inhibitor that demonstrates Aβ-lowering activity within a transgenic mouse model of Alzheimer's disease.</p>

CAS 935525-13-6

BMS 433796;

BMS 433796

Ref: 3D-FB104190

BMS 433796

Ref: TM-T14690